COLD-PCR enhanced melting curve analysis improves diagnostic accuracy for KRAS mutations in colorectal carcinoma

BMC Clinical Pathology

Volumn 10, Issue , 2010, Pages

  Pritchard, Colin C ^a   Akagi, Laura ^a   Reddy, Poluru L ^b   Joseph, Loren ^b   Tait, Jonathan F ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GUANINE NUCLEOTIDE BINDING PROTEIN; KIRSTEN RAT SARCOMA VIRUS HOMOLOG 2; UNCLASSIFIED DRUG;

ARTICLE; CO AMPLIFICATION AT LOWER DENATURATION TEMPERATURE; CODON; COLORECTAL CARCINOMA; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DNA SEQUENCE; GENE AMPLIFICATION; GENE MUTATION; HUMAN; HUMAN CELL; HUMAN TISSUE; MUTATIONAL ANALYSIS; POLYMERASE CHAIN REACTION; PROTEIN DENATURATION; SENSITIVITY ANALYSIS;

EID: 78649326419     PISSN: 14726890     EISSN: 14726890     Source Type: Journal    
DOI: 10.1186/1472-6890-10-6     Document Type: Article

References (24)

1. Biomarkers predicting clinical outcome of epidermal growth factor receptor-targeted therapy in metastatic colorectal cancer. S Siena A Sartore-Bianchi F Di Nicolantonio J Balfour A Bardelli, J Natl Cancer Inst 2009 101 19 1308 1324 10.1093/jnci/djp280 19738166
2. The COSMIC (Catalogue of Somatic Mutations in Cancer) database and website. S Bamford E Dawson S Forbes J Clements R Pettett A Dogan A Flanagan J Teague PA Futreal MR Stratton,, et al. Br J Cancer 2004 91 2 355 358 15188009
3. COSMIC (the Catalogue of Somatic Mutations in Cancer): a resource to investigate acquired mutations in human cancer. SA Forbes G Tang N Bindal S Bamford E Dawson C Cole CY Kok M Jia R Ewing A Menzies,, et al. Nucleic Acids Res 2010 38 Database 652 657 10.1093/nar/gkp995 19906727
4. K-ras mutations and benefit from cetuximab in advanced colorectal cancer. CS Karapetis S Khambata-Ford DJ Jonker CJ O'Callaghan D Tu NC Tebbutt RJ Simes H Chalchal JD Shapiro S Robitaille,, et al. N Engl J Med 2008 359 17 1757 1765 10.1056/NEJMoa0804385 18946061
5. Cetuximab and chemotherapy as initial treatment for metastatic colorectal cancer. E Van Cutsem CH Kohne E Hitre J Zaluski CR Chang Chien A Makhson G D'Haens T Pinter R Lim G Bodoky,, et al. N Engl J Med 2009 360 14 1408 1417 10.1056/NEJMoa0805019 19339720
6. Colorectal cancer molecular biology moves into clinical practice. CC Pritchard WM Grady, Gut 2010 20921207
7. Somatic EGFR mutations and efficacy of tyrosine kinase inhibitors in NSCLC. H Linardou IJ Dahabreh D Bafaloukos P Kosmidis S Murray, Nat Rev Clin Oncol 2009 6 6 352 366 10.1038/nrclinonc.2009.62 19483740
8. KRAS mutation is an important predictor of resistance to therapy with epidermal growth factor receptor tyrosine kinase inhibitors in non-small-cell lung cancer. E Massarelli M Varella-Garcia X Tang AC Xavier NC Ozburn DD Liu BN Bekele RS Herbst II Wistuba, Clin Cancer Res 2007 13 10 2890 2896 10.1158/1078-0432.CCR-06-3043 17504988
9. Replacing PCR with COLD-PCR enriches variant DNA sequences and redefines the sensitivity of genetic testing. J Li L Wang H Mamon MH Kulke R Berbeco GM Makrigiorgos, Nat Med 2008 14 5 579 584 10.1038/nm1708 18408729
10. COLD-PCR: a new platform for highly improved mutation detection in cancer and genetic testing. J Li GM Makrigiorgos, Biochem Soc Trans 2009 37 Pt 2 427 432 10.1042/BST0370427 19290875
11. RAS point mutations and PAX8-PPAR gamma rearrangement in thyroid tumors: evidence for distinct molecular pathways in thyroid follicular carcinoma. MN Nikiforova RA Lynch PW Biddinger EK Alexander GW Dorn G Tallini TG Kroll YE Nikiforov, J Clin Endocrinol Metab 2003 88 5 2318 2326 10.1210/jc.2002-021907 12727991
12. Sensitive sequencing method for KRAS mutation detection by Pyrosequencing. S Ogino T Kawasaki M Brahmandam L Yan M Cantor C Namgyal M Mino-Kenudson GY Lauwers M Loda CS Fuchs, J Mol Diagn 2005 7 3 413 421 16049314
13. The frequency of KRAS mutation detection in human colon carcinoma is influenced by the sensitivity of assay methodology: a comparison between direct sequencing and real-time PCR. T Kobunai T Watanabe Y Yamamoto K Eshima, Biochem Biophys Res Commun 2010 395 1 158 162 10.1016/j.bbrc.2010.03.167 20361930
14. Detection of low-level KRAS mutations using PNA-mediated asymmetric PCR clamping and melting curve analysis with unlabeled probes. JE Oh HS Lim CH An EG Jeong JY Han SH Lee NJ Yoo, J Mol Diagn 2010 12 4 418 424 10.2353/jmoldx.2010. 090146 20413678
15. A multicenter blinded study to evaluate KRAS mutation testing methodologies in the clinical setting. V Whitehall K Tran A Umapathy F Grieu C Hewitt TJ Evans T Ismail WQ Li P Collins P Ravetto,, et al. J Mol Diagn 2009 11 6 543 552 10.2353/jmoldx.2009.090057 19815694
16. COLD-PCR finds hot application in mutation analysis. R Luthra Z Zuo, Clin Chem 2009 55 12 2077 2078 10.1373/clinchem.2009.136143 19833831
17. The Use of COLD-PCR and High-Resolution Melting Analysis Improves the Limit of Detection of KRAS and BRAF Mutations in Colorectal Cancer. I Mancini C Santucci R Sestini L Simi N Pratesi F Cianchi R Valanzano P Pinzani C Orlando, J Mol Diagn 2010 12 5 705 711 10.2353/jmoldx.2010.100018 20616366
18. Comparison of Sanger sequencing, pyrosequencing, and melting curve analysis for the detection of KRAS mutations: diagnostic and clinical implications. AC Tsiatis A Norris-Kirby RG Rich MJ Hafez CD Gocke JR Eshleman KM Murphy, J Mol Diagn 2010 12 4 425 432 10.2353/jmoldx.2010.090188 20431034
19. European Medicines Agency: Committee for Medicinal Products for Human Use May 2008 Plenary Meeting monthly report. http://www.emea.europa.eu/pdfs/human/ press/pr/27923508en.pdf
20. National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines in Oncology: Colon Cancer V.2.2010 http://www.nccn.org/professionals/physician- gls/PDF/colon.pdf
21. Application of COLD-PCR for improved detection of KRAS mutations in clinical samples. Z Zuo SS Chen PK Chandra JM Galbincea M Soape S Doan BA Barkoh H Koeppen LJ Medeiros R Luthra, Mod Pathol 2009 22 8 1023 1031 10.1038/modpathol.2009.59 19430420
22. COLD-PCR-enhanced high-resolution melting enables rapid and selective identification of low-level unknown mutations. CA Milbury J Li GM Makrigiorgos, Clin Chem 2009 55 12 2130 2143 10.1373/clinchem.2009.131029 19815609
23. Increased sensitivity of KRAS mutation detection by High-Resolution Melting analysis of COLD-PCR products. LS Kristensen IL Daugaard M Christensen S Hamilton-Dutoit H Hager LL Hansen, Hum Mutat 2010 epub 20848649
24. Detection of rare mutant K-ras DNA in a single-tube reaction using peptide nucleic acid as both PCR clamp and sensor probe. JD Luo EC Chan CL Shih TL Chen Y Liang TL Hwang CC Chiou, Nucleic Acids Res 2006 34 2 12 10.1093/nar/gnj008 16432256